AAM
AMED

Advisors Asset Management’s Amedisys AMED Stock Holding History

Advisors Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,289
Closed -$124K – 1475
2024
Q3 		$124K Sell
1,289
-235
-15% -$22.9K ﹤0.01% 1188
2024
Q2 		$140K Sell
1,524
-510
-25% -$47.3K ﹤0.01% 1161
2024
Q1 		$187K Sell
2,034
-130
-6% -$12.2K ﹤0.01% 1142
2023
Q4 		$206K Buy
2,164
+10
+0.5% +$934 ﹤0.01% 1107
2023
Q3 		$201K Sell
2,154
-22
-1% -$2.03K ﹤0.01% 1111
2023
Q2 		$199K Sell
2,176
-776
-26% -$63.7K ﹤0.01% 1120
2023
Q1 		$217K Buy
2,952
+121
+4% +$10.5K ﹤0.01% 1096
2022
Q4 		$237K Buy
2,831
+1,381
+95% +$125K ﹤0.01% 1103
2022
Q3 		$140K Sell
1,450
-257
-15% -$30.6K ﹤0.01% 1207
2022
Q2 		$179K Sell
1,707
-783
-31% -$100K ﹤0.01% 1182
2022
Q1 		$429K Sell
2,490
-2,472
-50% -$369K 0.01% 1053
2021
Q4 		$803K Sell
4,962
-3,455
-41% -$555K 0.01% 877
2021
Q3 		$1.25M Sell
8,417
-4,239
-33% -$881K 0.02% 738
2021
Q2 		$3.1M Sell
12,656
-3,558
-22% -$934K 0.05% 441
2021
Q1 		$4.29M Sell
16,214
-5,056
-24% -$1.43M 0.07% 296
2020
Q4 		$6.24M Sell
21,270
-808
-4% -$207K 0.1% 187
2020
Q3 		$5.22M Sell
22,078
-4,500
-17% -$1.02M 0.1% 194
2020
Q2 		$5.28M Sell
26,578
-3,289
-11% -$613K 0.1% 192
2020
Q1 		$5.48M Sell
29,867
-3,410
-10% -$607K 0.13% 161
2019
Q4 		$5.55M Buy
33,277
+853
+3% +$127K 0.1% 244
2019
Q3 		$4.25M Sell
32,424
-9,002
-22% -$1.17M 0.08% 285
2019
Q2 		$5.03M Sell
41,426
-3,314
-7% -$393K 0.09% 266
2019
Q1 		$5.51M Buy
44,740
+6,144
+16% +$771K 0.1% 234
2018
Q4 		$4.52M Buy
38,596
+10,029
+35% +$1.18M 0.09% 258
2018
Q3 		$3.57M Buy
28,567
+11,486
+67% +$1.27M 0.06% 376
2018
Q2 		$1.46M Buy
+17,081
New +$1.25M 0.02% 705

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Advisors Asset Management's AMED Position: Q4 2024 in Review

Advisors Asset Management sold out of Amedisys (AMED) in Q4 2024, closing a stake of 1,289 shares — an estimated $124K sold.

Advisors Asset Management first reported a position in AMED in Q2 2018 and held it in 26 quarters. The position peaked at $6.24M in Q4 2020. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Advisors Asset Management reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Advisors Asset Management sold 1,289 Amedisys shares in Q4 2024, an estimated $124K.
  • Advisors Asset Management first reported a position in Amedisys in Q2 2018 and held it in 26 quarters.
  • Advisors Asset Management's Amedisys position peaked at $6.24M in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Advisors Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.